Guiding Innovation & Excellence

Our Scientific Advisory Board comprises a group of esteemed experts in the biotech field, who bring invaluable insights and extensive experience to the table. Their role is crucial in guiding our organization's decisions and initiatives, ensuring that our research, development, and innovation are at the forefront of the industry. Their perspectives help us address complex challenges and identify opportunities to drive scientific progress, ultimately supporting our mission to deliver breakthrough solutions in biotechnology.





Adit Ginde, MD, MPH

Vice Chair for Research, Dept. of Emergency Medicine, CU Anschutz
Director, CCTSI Trial Innovation Network
Director of Clinical Research, Dept. of Anesthesiology

Dr. Ginde's research focuses on conducting clinical trials across various healthcare settings, including emergency departments, ICUs, perioperative, and outpatient areas. His work is primarily centered on the early care of critically ill and injured patients, especially in the realms of acute respiratory failure and sepsis/infection, including COVID-19.


Keith Kaye, MD, MPH

Chief, Division of Allergy, Immunology and Infectious Diseases, Rutgers, Robert Wood Johnson Medical School
Past President, Society for Healthcare Epidemiology of America (SHEA)

Dr. Kaye is a renowned expert in the prevention and management of healthcare-associated infections, particularly those caused by multi-drug resistant (MDR) pathogens. His areas of expertise also encompass antimicrobial stewardship, infections in older adults, and surgical site infections.



Charles Chiu, MD, PhD

Professor, UCSF Depts. of Laboratory Medicine and Medicine – Infectious Diseases
Associate Director, UCSF Clinical Microbiology Laboratory

Dr. Chiu leads a translational research laboratory dedicated to developing clinical metagenomic next-generation sequencing assays for diagnosis of infectious diseases, host response profiling, pathogen discovery, and bioinformatics software development. His research also extends to nanopore sequencing and the characterization of emerging infections.


Geoffrey Ling, MD, PhD

Professor of Neurology, Uniformed Services Univ. of the Health Sciences
Professor of Neurology and Attending Physician, Neuro Critical Care, Johns Hopkins Hospital

Dr. Ling retired from the United States Army as a colonel and is the former Assistant Director for Medical Innovation at the White House. Dr. Ling also served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office, where his research portfolio included combining biomarkers and advanced analytics to diagnose disease in their presymptomatic stages. Dr. Ling is a recipient of the Department of Defense Medal for Distinguished Public Service, Legion of Merit, and the Order of Military Medical Merit.



Clinical Trial Leadership

Seasoned in designing and overseeing clinical trials across diverse healthcare settings, including ED, ICU, and outpatient environments. Leading multicenter trials and contributing to national clinical trial networks.

Infectious Disease Management

Experts in preventing and managing healthcare-associated infections, including multi-drug resistant pathogens. Proficient in antimicrobial stewardship, infections in older adults, and surgical site infections.

Genomic Medicine Advancements

Leading the way in advanced genomic sequencing for diagnostics, pathogen discovery, and bioinformatics, revolutionizing infectious disease diagnosis and research.

Immunology & Autoimmune Disease Research

Pioneering expertise in immunology with a focus on early care for critically ill patients and the development of clinical trials to support this.

Drug Development & Regulatory Affairs

Comprehensive knowledge in drug development and regulatory affairs, ensuring products meet industry standards and regulatory requirements.

Neurocritical Care

Experts in neurological care, including the prevention of brain injuries, development of responsive treatments, and advancements in critical care for various neurological conditions.

Questions for the Advisory Board?

Let us know what's on your mind!